1 312-422-1111
ibioadmin@ibio.org

Blog

HB 2026 DIGITAL FAIR REPAIR ACT – OPPOSE

Sponsor: Rep. Michelle Mussman (D)

Track Bill

Summary

Creates the Digital Fair Repair Act. Provides that original equipment manufacturers shall: (i) make available to any independent repair provider or owner of equipment manufactured by the original equipment manufacturer the same diagnostic and repair documentation in the same manner as that information is made available to the manufacturer’s authorized repair providers; and (ii) make available for purchase by the owner, his or her authorized agent, or any independent repair provider parts, inclusive of any updates to the embedded software of the parts, upon fair and reasonable terms. Requires original equipment manufacturers to make available for purchase by owners and independent repair providers all diagnostic repair tools incorporating the same diagnostic, repair, and remote communications capabilities that the original equipment manufacturer makes available to its own repair or engineering staff or an authorized repair provider. Requires an independent repair provider that purchases or acquires embedded software or service parts to notify the owner of the equipment in writing of certain warranties prior to performing any services on digital electronic equipment. Provides that, with one exception, an authorized provider shall have all the rights and remedies provided under the Act. Authorizes the Attorney General to seek to enjoin violations and to recover civil penalties. Requires the Attorney General to establish an outreach program to inform the public of rights under the Act. Defines terms. Excludes motor vehicle manufacturers. Provides for recovery of damages and attorney’s fees. Provides for the protection of trade secrets. Effective January 1, 2020.

Read more

IL ­ SB123 INC TAX­R AND D CREDIT – SUPPORT

Primary Sponsor: Senator Julie A. Morrison (D)

Track Bill

Summary:

Amends the Illinois Income Tax Act. Provides that the research and development credit applies on a permanent basis. Effective immediately.

Read more

IL ­ HB1470 MEDICAL DEVICE SAFETY – OPPOSE

Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill

Summary:

Creates the Medical Device Safety Act. Provides that (i) all medical devices to be used by, surgically applied to, or surgically implanted within a patient be under warranty, regardless of the severity of the patient’s medical condition necessitating the device, (ii) all persons and entities that produce, sell, offer for sale, or provide medical devices to be used by, surgically applied to, or surgically implanted within a patient are liable for all costs to the patient for the replacement of each medical device if the medical device malfunctions due to no fault of the patient, and (iii) all hospitals and ambulatory surgical treatment centers shall waive the costs charged to patients for follow­up surgeries that result from defective medical devices, regardless of whether or not those defective medical devices are capable of being implanted. Amends the University of Illinois Hospital Act, the Ambulatory Surgical Treatment Center Act, and the Hospital Licensing Act. Requires that the University of Illinois Hospital, all ambulatory surgical treatment centers, and all hospitals licensed under the Hospital Licensing Act waive the costs charged to patients for follow­up surgeries that result from previous surgical errors. Effective immediately.

Read more

IL ­ HB1441 IMPORTED PRESCRIPTION DRUGS – OPPOSE

Primary Sponsor: Representative Anna Moeller (D)

Track Bill

Summary

Creates the Wholesale Importation of Prescription Drugs Act. Requires the Department of Public Health to design an importation program where the State is the licensed wholesaler of imported drugs from licensed, regulated Canadian suppliers. Requires the program to address specified issues, including billing issues, cost savings issues, and safety and regulatory issues. Contains auditing and reporting requirements. Provides that the Department shall enlist the assistance of the Attorney General to identify the potential for anti­competitive behavior in industries that would be affected by an importation program. Requires the Department to submit a formal request to the Secretary of the United States Department of Health and Human Services for certification of the importation program. Requires the Department to have the program operational within 6 months after receiving the certification. Contains provisions concerning implementation requirements.

Read more

IL ­ HB349 DRUG AND SHARPS WASTE PROGRAM – OPPOSE

Creates the Drug and Sharps Waste Stewardship Act. Directs the Environmental Protection

Agency to administer a drug and sharps waste stewardship program.
Last Action: Referred to Rules Committee (January 14, 2019)
Primary Sponsor: Representative Kelly M. Cassidy (D)

Track Bill

Read more

IL ­ HB156 BIOLOGICAL PRODUCTS­ DRUG PRICE – OPPOSE

Creates the Prescription Drug Pricing Transparency Act. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are met).

Last Action: Assigned to Prescription Drug Affordability & Accessibility Committee (January 29, 2019)Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill

Read more

IL ­ HB53 DRUG MANUFACTURER­ DISCLOSURES – OPPOSE

Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3 days after approval by the U.S. Food and Drug Administration

Last Action: Assigned to Prescription Drug Affordability & Accessibility Committee (January 29, 2019)Primary Sponsor: Representative Mary E. Flowers (D)

Track Bill

Read more

iBIO’s StellarGirls After School Program Expands into North Chicago

We are excited to announce that the StellarGirls program will expand into North Chicago. The Neal Math and Science Academy will provide the program to all of their 98 girls in 6th grade.

Read more

BioVie Receives $3.2 Million Equity Investment

On July 3, 2018, BioVie Inc. (OTCQB: BIVI), an iBIO PROPEL company developing innovative drug therapies for liver disease, executed an agreement with Acuitas Group Holdings, LLC (“Acuitas”) and certain other investors to purchase $3.2 million of the Company’s Series A Preferred Stock

Read more

The iBIO Institute Honors Life Sciences Educators, Innovators and Entrepreneurs at the 12th Annual iCON Awards

This evening, the iBIO Institute hosted the twelfth annual iCON awards last night at The Chicago Botanic Garden.

Read more